🔴 Moleculin Biotech is trading 21.18% down today after announcing a 1-for-20 reverse stock split

Moleculin Biotech is trading at $0.22, down 21.18%, after announcing a 1-for-20 reverse stock split effective October 20, 2026.

• The company said the split will reduce outstanding shares from approximately 20.9 million to 1.05 million.
• The announcement preceded a sharp decline, and shares continued lower on October 19.
• The provided price history shows consecutive declines on October 14, 15 and 16.